TV3326

Known as: TV 3326 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2010
012320002010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
The recent therapeutic approach in which drug candidates are designed to possess diverse pharmacological properties and act on… (More)
Is this relevant?
2004
2004
We have recently shown that the anti-Parkinson-propargyl-containing monoamine oxidase B (MAO-B) inhibitor drug, rasagiline [N… (More)
Is this relevant?
2003
2003
(R)-[(N-propargyl-(3R) aminoindan-5-yl) ethyl methyl carbamate] (TV3326) is a novel cholinesterase and brain-selective monoamine… (More)
Is this relevant?
2003
2003
Two novel neuroprotective cholinesterase (ChE) inhibitors, TV3326 and TV3279 [(N-propargyl-(3R) and (3S) aminoindan-5-yl)-ethyl… (More)
Is this relevant?
2003
2003
The anti Parkinson drug, rasagiline [R-(+)-N-propargyl-1-aminoindan], an inhibitor of type B monoamine oxidase, has been shown to… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2003
2003
(N-propargyl-(3R)-aminoindan-5-yl)-ethyl, methyl carbamate (TV3326), a known neuroprotective agent exhibiting the properties of… (More)
Is this relevant?
2002
2002
Rationale: A high incidence of depression is found in subjects with Alzheimer's disease (AD), in whom many antidepressants are… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2002
2002
Two novel neuroprotective cholinesterase (ChE) inhibitors, TV3326, (N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamate, and… (More)
Is this relevant?
2001
2001
TV3326, (N-propargyl-(3R)-aminoindan-5-yl-ethyl,methyl carbamate) was prepared in order to combine the neuroprotective effects of… (More)
Is this relevant?
2000
2000
TV3326, [(N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamate] is a novel aminoindan derivative of the selective… (More)
Is this relevant?